Potential killer in the ICU-severe tuberculosis combined with hemophagocytic syndrome A case series and literature review

被引:10
作者
Chen, Lulu [1 ]
Weng, Heng [1 ]
Li, Hongyan [1 ]
Huang, Jinbao [1 ]
Pan, Jianguang [1 ]
Huang, Yansheng [1 ]
Ma, Chenhui [1 ]
机构
[1] Fuzhou Pulm Hosp Fujian, Dept Resp Dis, Fuzhou 350008, Fujian, Peoples R China
关键词
hemophagocytic syndrome; respiratory failure; tuberculosis; LYMPHOHISTIOCYTOSIS; INFECTION; SECONDARY;
D O I
10.1097/MD.0000000000009142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophagocytic syndrome (HPS) is a life-threatening clinical syndrome that has various presentations, shows rapid progression and is associated with a high mortality. Clinical reports about pulmonary tuberculosis combined with respiratory failure accompanied by HPS are rare. HPS has no special clinical manifestations, and the main presentations include persistent fever, hepatosplenomegaly, hematocytopenia, and rash. In the Intensive Care Unit (ICU), the clinical manifestations of severe infection and secondary HPS overlap, thus there is often a delay in the diagnosis and treatment of HPS. HPS is not an independent disease but represents an excessive inflammatory response due to immune dysfunction induced by various causes such as infection and tumor. The 2 cases in this report show that tuberculosis-associated hemophagocytic syndrome is not easy to find, especially in ICU. There are few clinical reports of pulmonary tuberculosis combined with respiratory failure and HPS. Here, we describe 2 such clinical cases and review the relevant literature in order to deepen our understanding of this disease.
引用
收藏
页数:5
相关论文
共 17 条
[1]  
Fernández AA, 2017, INT J MYCOBACT, V6, P108, DOI 10.4103/ijmy.ijmy_14_17
[2]   Association of Crohn's Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis [J].
Biank, Vincent F. ;
Sheth, Mehul K. ;
Talano, Julie ;
Margolis, David ;
Simpson, Pippa ;
Kugathasan, Subra ;
Stephens, Michael .
JOURNAL OF PEDIATRICS, 2011, 159 (05) :808-812
[3]   Tuberculosis-associated haemophagocytic syndrome [J].
Brastianos, Priscilla K. ;
Swanson, Jordan W. ;
Torbenson, Michael ;
Sperati, John ;
Karakousis, Petros C. .
LANCET INFECTIOUS DISEASES, 2006, 6 (07) :447-454
[4]   Critical care management of patients with hemophagocytic lymphohistiocytosis [J].
Buyse, Sophie ;
Teixeira, Luis ;
Galicier, Lionel ;
Mariotte, Eric ;
Lemiale, Virginie ;
Seguin, Amelie ;
Bertheau, Philippe ;
Canet, Emmanuel ;
de Labarthe, Adrienne ;
Darmon, Michael ;
Rybojad, Michel ;
Schlemmer, Benoit ;
Azoulay, Elie .
INTENSIVE CARE MEDICINE, 2010, 36 (10) :1695-1702
[5]   Cell-Mediated Immune Responses in Tuberculosis [J].
Cooper, Andrea M. .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :393-422
[6]  
Fang M, 2015, J INTERN INTENSIVE M, V21, P86
[7]  
Gao L, 2016, J CLIN HEMATOL, V29, P354
[8]   Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? [J].
Grom, AA .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) :587-590
[9]  
Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO
[10]  
2-H